https://www.selleckchem.com/products/nlg919.html
86, 95% CI, 0.71-1.03) nor in HCQ plus AZM treatment group (RR 1.28, 95% CI, 0.76-2.14) in comparison to controls. Meta-regression analysis showed that age was the factor that significantly affected mortality ( 0.00001). The meta-analysis found that there was no clinical benefit of using either HCQ by itself or in combination with AZM for the treatment of COVID-19 patients. Hence, it may be prudent for clinicians and researchers to focus on other therapeutic options that may show greater promise in this disease. The meta-analysis fou
Like
Comment
Share
